Trials / Terminated
TerminatedNCT02925676
Evaluation of the Hypoglycaemia Notification Device Hyposafe H02
Evaluation of the Hypoglycaemia Notification Device Hyposafe H02 - the Pilot 2 Study - in Subjects With Type 1 Diabetes
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- UNEEG Medical A/S · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the technical performance of the hyposafe H02 during everyday activities and during insulin-induced hypoglycaemia, in addition to safety issues associated with the implantation and use of the hyposafe H02 in subjects with type 1 diabetes.
Detailed description
While a finger prick test accurately measures the blood glucose level, it does not provide continuous measurements and hence it is unreliable as a hypoglycaemia notification. Recent studies have indicated that the use of continuous glucose monitoring (CGM) reduces the risk of severe hypoglycaemia. However, some find these devices troublesome to use and are annoyed by the inaccuracy of the measurements and even after short-term use the coverage in subgroups of patients is as low as 50% of the time. Thus, there is a medical need for a reliable hypoglycaemia notification which is easy and convenient to use and with high sensitivity and high rate of positive prediction. This clinical investigation is designed to evaluate the sensitivity and the positive predictive value of the Hyposafe H02 in subjects with type 1 diabetes during everyday activities and during insulin-induced hypoglycaemia. In addition, the investigation provides information regarding safety and usability of the device. This to verify that the Hyposafe H02 works as intended in subjects with type 1 diabetes before proceeding with a larger study in subjects with type 1 diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | hyposafe H02 | hypoglycaemia notification device |
Timeline
- Start date
- 2016-10-05
- Primary completion
- 2018-08-29
- Completion
- 2018-09-10
- First posted
- 2016-10-06
- Last updated
- 2024-07-26
- Results posted
- 2024-07-26
Locations
2 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02925676. Inclusion in this directory is not an endorsement.